@mattherder.bsky.social

law prof

"Defending against emerging diseases is literally a matter of life & death. Our government’s negligence endangers us" I do think RFK Jr & Bhattacharya killing mRNA vaccine R&D, & Bhattacharya killing federal funding for pandemic research & pushing for no preparedness at all, were unforgivable acts

Elizabeth Jacobs, PhD@elizabethjacobs.bsky.social · 3mo ago

I want to share the new OpEd that @jimalwine.bsky.social and I wrote about the dangerous lack of pandemic preparedness in the United States. It doesn’t matter how the outbreak begins. We are not ready, and the only things we can be sure of are death, taxes, and another pandemic.

Today, MSF is going public with something we've been fighting behind closed doors for months: Gilead will not sell us their new HIV drug, lenacapavir. The sticking point isn't even price, they just refuse to sell. Open letter linked + explainer 🧵1/ www.doctorswithoutborders.org/latest/gilea...

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

Blocking humanitarian organizations from accessing a medical breakthrough puts vulnerable people across the world in danger.

doctorswithoutborders.org

"If high-level officials at the FDA are interested in the new use of a drug, they should lead with evidence, not with approval, and outline a process to ensure decisional integrity."

Daniel G. Aaron, MD, JD@medlawdan.bsky.social · 8mo ago

NEW: Paper in @jama.com (me, Glenn Cohen, & @drsinhaesq.bsky.social) discusses FDA plan to approve leucovorin for new indication based on "case reports" and "mechanistic data" 1. Departure from FDA's evidentiary standards 2. May harm patients and set bad precedent jamanetwork.com/journals/jam...

Thrilled to see this paper led by Ipek Erin Vural out in Social Science & Medicine In it, we reflect on how regulators both collaborate + compete with one another, mediating the tension between capital accumulation + public trust that sits behind regulation. www.sciencedirect.com/science/arti...

Competitive Interdependence: A Critical Political Economy of Regulation during the COVID-19 Pandemic.

This article investigates Canada's health product regulatory authority, Health Canada (HC), and other major national regulators' responses to COVID-19…

sciencedirect.com

Still incredibly disappointing that Canada can look at the consequences of aid cuts by other countries earlier this year, and then not only put out a budget that slashes $2.7 billion from international assistance, but put that $2.7 billion in a column labelled "savings".

The New Yorker@newyorker.com · 9mo ago

One analytical model shows that, as of November 5th, the dismantling of U.S.A.I.D. has already caused the deaths of 600,000 people, two-thirds of them children. https://newyorkermag.visitlink.me/jUzNSc

CUSMA vs the USMCA / A short thread. As many pundits have pointed out amidst trade tensions + tariffs between Canada and the US, it's important to keep an eye on the prize, i.e. the upcoming negotiations over the trade deal between Canada, the US, and Mexico. In Canada, we call it 'CUSMA'.

Bad to much worse: www.statnews.com/2025/11/03/g... When NYT broke news of Tidmarsh's leave, it seemed maybe he was being retaliated against for criticizing commissioner's vouchers. Now it seems he may have used his FDA role for personal vendettas+possible extortion. The civil complaint is shocking.

Lawsuit against top FDA drug regulator is packed with incendiary texts, emails

A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts and emails

statnews.com